As of the 9 month 10Q ACT's revenues were down from prior year due to license terminations. Settlement losses will be high again due to lawsuits and old debts being paid via "fairness hearings". R&D expense will be much higher due to approx. $3MM charge added on for Lanzas 30MM gifted shares. General & Administrative is up huge due to $10MM charge for approx.106MM gifted shares to Caldwell and BOD's. Nothing will be close to positive in this section.
2)cash flows from investing activities most likely negative again
3)cash flows from financing activities This will be positive because we issued a boat load of shares to have monies in the bank at year end.(financing)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.